IRIS Accounts Production v25.1.3.33 04280406 Board of Directors 1.4.24 31.3.25 31.3.25 false true false false true false 'A' Ordinary 1.00000 'B' Ordinary 1.00000 'C' Ordinary 1.00000 'D' Ordinary 1.00000 'E' Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh042804062024-03-31042804062025-03-31042804062024-04-012025-03-31042804062023-03-31042804062023-04-012024-03-31042804062024-03-3104280406ns15:EnglandWales2024-04-012025-03-3104280406ns14:PoundSterling2024-04-012025-03-3104280406ns10:Director12024-04-012025-03-3104280406ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3104280406ns10:SmallEntities2024-04-012025-03-3104280406ns10:AuditExemptWithAccountantsReport2024-04-012025-03-3104280406ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3104280406ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3104280406ns10:FullAccounts2024-04-012025-03-3104280406ns10:OrdinaryShareClass12024-04-012025-03-3104280406ns10:OrdinaryShareClass22024-04-012025-03-3104280406ns10:OrdinaryShareClass32024-04-012025-03-3104280406ns10:OrdinaryShareClass42024-04-012025-03-3104280406ns10:OrdinaryShareClass52024-04-012025-03-3104280406ns10:Director22024-04-012025-03-3104280406ns10:Director32024-04-012025-03-3104280406ns10:Director42024-04-012025-03-3104280406ns10:Director52024-04-012025-03-3104280406ns10:CompanySecretary12024-04-012025-03-3104280406ns10:RegisteredOffice2024-04-012025-03-3104280406ns5:CurrentFinancialInstruments2025-03-3104280406ns5:CurrentFinancialInstruments2024-03-3104280406ns5:ShareCapital2025-03-3104280406ns5:ShareCapital2024-03-3104280406ns5:CapitalRedemptionReserve2025-03-3104280406ns5:CapitalRedemptionReserve2024-03-3104280406ns5:RetainedEarningsAccumulatedLosses2025-03-3104280406ns5:RetainedEarningsAccumulatedLosses2024-03-3104280406ns5:PlantMachinery2024-04-012025-03-3104280406ns5:LeaseholdImprovements2024-03-3104280406ns5:PlantMachinery2024-03-3104280406ns5:ComputerEquipment2024-03-3104280406ns5:LeaseholdImprovements2024-04-012025-03-3104280406ns5:ComputerEquipment2024-04-012025-03-3104280406ns5:LeaseholdImprovements2025-03-3104280406ns5:PlantMachinery2025-03-3104280406ns5:ComputerEquipment2025-03-3104280406ns5:LeaseholdImprovements2024-03-3104280406ns5:PlantMachinery2024-03-3104280406ns5:ComputerEquipment2024-03-3104280406ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3104280406ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3104280406ns5:CurrentFinancialInstruments2024-04-012025-03-3104280406ns10:OrdinaryShareClass12025-03-3104280406ns10:OrdinaryShareClass22025-03-3104280406ns10:OrdinaryShareClass32025-03-3104280406ns10:OrdinaryShareClass42025-03-3104280406ns10:OrdinaryShareClass52025-03-31
REGISTERED NUMBER: 04280406 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

FOR

MINTA MEDICAL LIMITED

MINTA MEDICAL LIMITED (REGISTERED NUMBER: 04280406)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025










Page

Company Information 1

Chartered Accountants' Report 2 to 3

Balance Sheet 4 to 5

Notes to the Financial Statements 6 to 8


MINTA MEDICAL LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2025







DIRECTORS: R Edwards
M A Edwards
A R Edwards
Mrs I J Edwards
Mrs T Edwards





SECRETARY: M A Edwards





REGISTERED OFFICE: Caddick Road
Knowsley Business Park
Knowsley
Merseyside
L34 9HP





REGISTERED NUMBER: 04280406 (England and Wales)

CHARTERED ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS
ON THE UNAUDITED FINANCIAL STATEMENTS OF
MINTA MEDICAL LIMITED


The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Directors are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Minta Medical Limited for the year ended 31 March 2025 which comprise the Income Statement, Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the Board of Directors of Minta Medical Limited, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Minta Medical Limited and state those matters that we have agreed to state to the Board of Directors of Minta Medical Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Minta Medical Limited and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that Minta Medical Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Minta Medical Limited. You consider that Minta Medical Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Minta Medical Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Malthouse & Company Chartered Accountants
America House, Rumford Court
Rumford Place
Liverpool
Merseyside
L3 9DD



CHARTERED ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS
ON THE UNAUDITED FINANCIAL STATEMENTS OF
MINTA MEDICAL LIMITED


21 May 2025

MINTA MEDICAL LIMITED (REGISTERED NUMBER: 04280406)

BALANCE SHEET
31 MARCH 2025

31.3.25 31.3.24
Notes £    £    £   
FIXED ASSETS
Tangible assets 4 162,088 171,687

CURRENT ASSETS
Stocks 1,487,253 1,688,418
Debtors 5 1,082,488 595,869
Cash at bank and in hand 965,383 317,693
3,535,124 2,601,980
CREDITORS
Amounts falling due within one year 6 805,859 313,604
NET CURRENT ASSETS 2,729,265 2,288,376
TOTAL ASSETS LESS CURRENT
LIABILITIES

2,891,353

2,460,063

PROVISIONS FOR LIABILITIES 14,960 14,935
NET ASSETS 2,876,393 2,445,128

CAPITAL AND RESERVES
Called up share capital 7 7,500 7,500
Capital redemption reserve (123,635 ) (123,635 )
Retained earnings 2,992,528 2,561,263
SHAREHOLDERS' FUNDS 2,876,393 2,445,128

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

MINTA MEDICAL LIMITED (REGISTERED NUMBER: 04280406)

BALANCE SHEET - continued
31 MARCH 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 21 May 2025 and were signed on its behalf by:





M A Edwards - Director


MINTA MEDICAL LIMITED (REGISTERED NUMBER: 04280406)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025


1. STATUTORY INFORMATION

Minta Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 20% on reducing balance and 5% on cost

Fixed assets are initially recognised at cost.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


MINTA MEDICAL LIMITED (REGISTERED NUMBER: 04280406)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 24 (2024 - 24 ) .

4. TANGIBLE FIXED ASSETS
Improvements
to Plant and Computer
property machinery equipment Totals
£    £    £    £   
COST
At 1 April 2024 173,803 228,015 27,333 429,151
Additions - 16,940 1,069 18,009
At 31 March 2025 173,803 244,955 28,402 447,160
DEPRECIATION
At 1 April 2024 78,703 160,614 18,147 257,464
Charge for year 8,691 16,866 2,051 27,608
At 31 March 2025 87,394 177,480 20,198 285,072
NET BOOK VALUE
At 31 March 2025 86,409 67,475 8,204 162,088
At 31 March 2024 95,100 67,401 9,186 171,687

MINTA MEDICAL LIMITED (REGISTERED NUMBER: 04280406)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Trade debtors 1,040,988 573,330
Other debtors 41,500 22,539
1,082,488 595,869

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Trade creditors 200,717 115,947
Taxation and social security 556,849 157,725
Other creditors 48,293 39,932
805,859 313,604

Other creditors include £5,283 in respect of pension contributions (2024 £3,597).

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.3.25 31.3.24
value: £    £   
1,250 'A' Ordinary £1 1,250 1,250
1,250 'B' Ordinary £1 1,250 1,250
1,250 'C' Ordinary £1 1,250 1,250
1,250 'D' Ordinary £1 1,250 1,250
1,250 'E' Ordinary £1 1,250 1,250
1,250 'F' Ordinary £1 1,250 1,250
7,500 7,500

8. RELATED PARTY DISCLOSURES

During the year, dividends totalling £1,928,844 (2024 £1,711,878) were paid to the directors.

During the year, the company paid rent of £71,006 to the directors.

9. ULTIMATE CONTROLLING PARTY

The company was controlled throughout the period by the directors.